
Amol Rakkar
Physician · Palo Verde Hematology Oncology LTD
Credentials: · · · ·
History
- Present
Palo Verde Hematology Oncology LTD
- 2001–2003
Medical Oncology
- 1998–2001
Internal Medicine
- 1994–1998
Government Medical College
Research
Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27
Cancer Research · 1997 · 308 citations
Biochemical and Biophysical Research Communications · 1998 · 49 citations
Frequency and management of thrombocytopenia with the glycoprotein IIb/IIIa receptor antagonists
Review · The American Journal of Cardiology · 2006 · Last of 3 authors · 46 citations
- KC
6 papers
- AN
1 paper
- BM
1 paper
- CK
1 paper

1 paper

1 paper

1 paper

1 paper
Clinical trials
- 2025–2029
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Site PI · Recruiting · Phase 3
Nuvalent Inc.

